2024 Inaugural Symposium on Kidney Transplantation in Plasma Cell Disorders — On Demand

We’re excited to offer an on-demand option for the Inaugural Symposium on Kidney Transplantation in Plasma Cell Disorders, originally held live on September 12, 2024 in New York City. This program features multidisciplinary experts from Memorial Sloan Kettering Cancer Center and around the world, spanning specialties such as hematology, nephrology, surgery, pathology, immunology, and bioethics. Presentations address essential topics related to the evaluation and management of plasma cell dyscrasia patients being considered for kidney transplantation, including:

• Updates in MGRS pathology and classification;
• The latest developments in clone-directed therapy and outcomes;
• Assessing depth of response;
• Updates on transplant biology and immunology;
• Complications of renal transplantation in patients with plasma cell disease; and
• Fair distribution of a scarce resource and role of living donor transplantation.

Additionally, the program includes a patient and clinician roundtable discussion, as well as a workshop on best practices for managing distinct disease entities.

For further information about the content available in this on-demand program, please refer to the brochure from the live course.

Objectives

1. Describe the pathology and classification of the distinct subtypes of MGRS
2. Summarize the updates in treatment and outcome assessment in the common plasma cell dyscrasias including multiple myeloma, light chain amyloidosis and MIDD
3. Review the methods for assessing depth of response in plasma cell disorders and their added value and limitations
4. Explain critical components of transplant biology and immunology that inform renal transplant practice
5. Describe common complications of renal transplantation and management
6. Discuss barriers to access to renal transplantation, strategies improve more equitable distribution and the role of living donor transplantation